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The WISP-3 gene was stably expressed in an immortalised
chondrocytic cell line (C-28/I2) to investigate the effects of WISP-
3 on chondrocyte biology. The expression of cartilage speciﬁc
genes was compared by real time PCR in clonal cells stably
transfected with WISP-3 or the empty vector alone. Results in
the WISP-3 stably expressing cells were veriﬁed by treating
untransfected parental C-28/I2 cells with recombinant human
WISP-3 protein.
The potential role of WISP-3 in cell signalling was investigated
by treating C-28/I2 cells with WISP-3 alone, IGF-1 alone or
IGF-1 and WISP-3 together. Erk1/2 phosphorylation was then
measured by western blotting after treatment for 10 minutes or 1
hour.
Results: Real time PCR revealed WISP-3 mRNA was upregu-
lated in osteoarthritic cartilage compared to normal post mortem
cartilage. Immunohistochemical staining of osteoarthritic and
post mortem cartilage sections showed WISP-3 protein was
present in damaged areas. In severely damaged cartilage sec-
tions, WISP-3 often appeared as strong halos around chondro-
cytes.
Stable over-expression of WISP-3 in C-28/I2 cells led to a down-
regulation of Col2a1 mRNA. Preliminary results suggest this
effect can also be produced by treatment of parental C-28/I2
cells with recombinant WISP-3 protein.
Treatment of C-28I/2 cells with IGF-1 induced Erk1/2 phos-
phorylation after 10 minutes. WISP-3 could also induce Erk1/2
phosphorylation, although when in combination with IGF-1 it did
not appear to enhance or prolong Erk1/2 phosphorylation.
Conclusions: Our data suggest that WISP-3 may be a marker
for damaged cartilage and may exert effects on matrix synthesis
and chondrocyte signalling. Further work is required to determine
the role of WISP-3 in cartilage matrix metabolism. We intend to
assess the effec ts of WISP-3 on metalloproteinase expression,
proliferation and IGF-1 induction of Col2a1 in C-28/I2 cells.
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Purpose: IKKα and IKKβ are essential kinases for activating NF-
κB transcription factors that regulate cellular differentiation and
inﬂammation. By virtue of their small size and ECM diffusibility
chemokines could invoke cross-talk between osteoarthritis (OA)
chondrocytes with other joint compartments and also contribute
to immune cell chemotaxis into the synovial space. Because
many chemokines are known to be direct NF-κB targets, here
we employed shRNA retroviruses to ablate the expression of
each IKK to determine their individual contributions for monocyte
chemotaxis in response to chondrocyte conditioned media.
Methods: Primary chondrocytes were derived from 6 OA pa-
tients undergoing joint arthroplasty. IKKα or IKKβ shRNAs were
stably expressed by pSuper retroviral transduction of IKKα or
IKKβ speciﬁc shOligos followed by selection of puromycin re-
sistant cells and KD efﬁciencies were veriﬁed by immunoblot-
ting. High density monolayer or micromass cultures were es-
tablished for each patient. Conditioned media was collected,
with or without 72 h of prior exposure to IL-1β. Chemotaxis
of human monocytes towards chondrocyte conditioned media
was assessed with boyden chambers. The chemokine expres-
sion repertoires under basal and stimulated conditions in wild
type and IKK KD chondrocytes were evaluated by focused
Oligo GEarrays (SuperArray) and the concentrations of monocyte
active chemokines (CCL2/MCP-1, CCL3/MIP-1α, CCL4/MIP-1β,
CCL5/RANTES) were also quantiﬁed by Multiplex ﬂuorescence-
based assays.
Results: Penetrant IKKα or IKKβ KDs of 80-90% blunted the
monocyte chemotactic potential of chondrocyte conditioned me-
dia. Under basal conditions CCL2/MCP-1 was the chemokine
of highest concentration (nanogram levels) in wild type chon-
drocyte conditioned media, which presented the strongest asso-
ciation with monocyte chemotaxis (Spearman=0.943, p<0.05).
Interestingly CCL2/MCP-1 production was co-dependent on IKKα
and IKKβ, while stimulus induced expression of CCL3/MIP-1α,
CCL4/MIP-β and CCL5/RANTES appeared to be largely depen-
dent on IKKα and not IKKβ. Similar results were obtained for
CCL5/RANTES at the RNA level after IL-1 stimulation for either
2 or 8 hours.
Conclusions: Results of targeted retroviral mediated RNA inter-
ference revealed a co-dependency on IKKα and IKKβ for mono-
cyte chemotaxis in response to chondrocyte conditioned media,
even in the absence of an extracellular pro-inﬂammatory stimulus
(i.e., IL-1β). Interestingly at least part of the dual IKK dependency
for this inﬂammatory-like migration response was associated with
the magnitude of MCP-1 production. Moreover IKKα and IKKβ
appear to be constitutively active in OA chondrocytes, because
chondrocyte conditioned media induced a strong migration re-
sponse by primary monocytes under basal conditions, likely
reﬂecting the synovitis often complicating OA. Our ﬁndings re-
veal important roles of both NF-κB activating kinases in driving
a key inﬂammatory process underlying this debilitating disease.
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Purpose: MMP-13 is a key protease in osteoarthritis (OA) patho-
physiology, and this protease is able to degrade a wide range
of cartilage matrix molecules. Our previous studies have shown
that human OA chondrocytes could be classiﬁed into two broad
categories, L- (Low) and H- (High) OA chondrocytes according
to their MMP-13 basal levels and IL-1β inducibility. L-OA chon-
drocytes had low MMP-13 basal levels and high IL-1β inducibility,
whereas H-OA chondrocytes showed high basal levels and low
IL-1β inducibility. Moreover, MMP-13 is regulated in H-OA chon-
drocytes by the proteins NMP4 and p130cas acting at the AGRE
site in the MMP-13 promoter. The aim of this study was to identify
factors involved in MMP-13 regulation in human L-OA chondro-
cytes and to determine the effect of IL-1β on these factors and
their roles. Furthermore, the effects of these factors were also
assessed on the expression of other MMPs.
Methods: Gel shift assays were done with AGRE-oligonu-
cleotides and human L-OA chondrocyte nuclear extracts; the
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proteins in the speciﬁc DNA/protein complex were identiﬁed by
mass spectrometry. siRNAs speciﬁc for p130cas and Hsp90 were
transfected, alone or in combination, into L-OA chondrocytes,
and the cells were incubated in the absence or presence of IL-1β
(100 pg/ml). Total RNA was extracted and processed for real-
time PCR with primers speciﬁc for the MMP-1, -2, -3, -9, -13 and
-14 genes. MMP-1 and -13 protein production was determined
by speciﬁc ELISAs.
Results: Mass spectrometry data revealed the presence of the
Hsp90 protein in the L-OA gel shift complex. siRNA experiments
on L-OA chondrocytes showed that p130cas and Hsp90 silenc-
ing signiﬁcantly increased the expression of MMP-13 (3.5 fold;
p<0.0001, and 1.8 fold; p<0.05, respectively) and, to a lesser ex-
tent, MMP-1 (2.2 fold; p<0.0001, and 1.6 fold; p<0.05), whereas
NMP4 showed no effect. These results point to an in vivo in-
hibitory role of p130cas and Hsp90 on these MMPs. The expres-
sion of MMP-2, -3, -9 and -14 was not affected by either factor.
Interestingly, the double silencing Hsp90/p130cas produced an
additive effect on MMP-13 expression (4.9 fold; p<0.0001), while
the effect on MMP-1 was minimal (2.3 fold; p<0.005). MMP-13
and MMP-1 protein levels are reminiscent of the expression pat-
tern. The presence of IL-1β with the p130cas-silenced cells, and
to some extent with the Hsp90-silenced cells, further stimulated
MMP-13 expression, suggesting that in vivo the presence of
these factors prevents a maximal stimulation by IL-1β.
Conclusions: This study identiﬁes the intracellular proteins
p130cas and Hsp90 as inhibitors of MMP-13 expression in L-
OA chondrocytes, and demonstrates the complexity of MMP-13
regulation. Studies are underway to determine if p130cas and
Hsp90 act independently or in cooperation.
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Purpose: Determine if resistin is present in the joint following
joint injury and in primary osteoarthritis (OA) and to elucidate the
role of resistin in cartilage inﬂammation and degradation in vitro.
Abstract 153 – Figure 1
Methods: The level of resistin was measured in paired synovial
ﬂuid and serum samples from patients following joint injury (ACL
or meniscus tear), primary OA, and non-injury/non-OA controls
using adipokine multiplex kits. Localization of resistin in joint tis-
sues was visualized by immunohistochemistry (IHC) in synovial
tissue and cartilage from OA, rheumatoid arthritis (RA), and
normal controls. Murine cartilage explants were treated with re-
combinant resistin for three days in culture. Release of cytokines
was assayed in the supernatants using a cytokine multiplex kit.
Inﬂammatory marker, PGE2, was measured in culture super-
natants by ELISA. Matrix degradation was visualized in Toluidine
Blue stained cartilage sections and quantiﬁed by measuring re-
lease of sulfated GAG (sGAG) to the culture media using the
dimethylmethylene blue (DMMB) dye assay.
Results: Resistin was detected in synovial ﬂuid and serum
samples immediately after joint meniscus and ligament injury and
in the early stage of OA. The level of resistin in both synovial ﬂuid
and serum declined with increasing time after injury from 3000
pg/ml to 900 pg/ml in synovial ﬂuid and 8550 pg/ml to 5200 pg/ml
in serum. Resistin protein was detected by IHC in macrophages
and mast cells in synovial tissue from both OA and RA patients.
Cartilage was negative for resistin staining in 3/3 OA and 2/3
RA samples. Cartilage explants treated in vitro with resistin at
10 µg/ml released increased levels of MCP-1, KC (functional
homolog of human IL-8), IL-6, and PGE2 compared to untreated
control cultures (Fig. 1). Resistin stimulated degradation and
release of sGAG from the cartilage extracellular matrix.
Conclusions: Resistin is present in the joint following injury and
in primary OA and causes the release of inﬂammatory markers
and cartilage matrix degradation in vitro. Inhibition of resistin in a
diseased joint has the potential to prevent joint inﬂammation and
cartilage degradation.
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Purpose: Mitogen-activated protein kinase-activated protein
